health Insurance

First-class journalism requires a high investment. Please share this article with others on the link below, cut and paste the article does not. See our Terms and Conditions and Copyright Policy for further details. E-mail@ft.com ftsales.support additional rights.As pharmaceutical companies feel the financial pressure on people not taking their medications properly to buy, health authorities have the consultants feel the benefits.Healthy interactions, a consultancy has gained funding from pharmaceutical companies including Eli Lilly for its programs that bring together patients with self-help groups that developed the game board in order to follow medical advice can be played.

It belongs to a growing number of companies looking for business as strategic opportunities to patients "adherence" to support the sale of products and to convince them that health systems are of high drug prices are better researched Fied. Richard Clark, president and CEO of Merck, said: "The statistics show that half of the patients, their medications as prescribed, if you could improve, we could save billions of dollars in hospitalization and treatment.". Patients in clinical trials under the supervision of their medication reliably and delivers impressive results often regulatory and health systems drugs.But to approve new results on large groups of patients using once a drug comes to market are often less impressive, partly because the drugs are not taken be as directed. The patient may run short of funds to buy them, they suffer side effects or simply forgetting.

Governments, insurance companies and others to buy the drugs are less willing to pay for it, if the impact on patients variable.Paul Lasiuk, founder of Healthy Interactions, says his company's approach: "The patient can spend hours in a year with your doctor to remember 20 percent of something, they said, and half of those who get the wrong information. There is a train wreck. It is not to say things, but for forwarding to their own conclusions.

Joe Jimenez, head of Novartis Pharma, says he has seen the fulfillment of the bad drugs for chronic diseases and even organ transplants. "Great players are very interested in meeting and pharmaceutical companies are not very good at it," he says.

Mr. Jimenez is with the consultant Proteus Biomedical, a small chip that is in each pill, which is ordered by a receiver detects work produced. When patients take their medications receive a notification via SMS.

Other big pharmaceutical companies have adopted different tactics. Pfizer has the world's largest, Health Solutions, support from nurses, patients, or phone to check their health and to encourage them to visit the best medical advice to follow you created. Johnson & Johnson has two companies that are trying to improve the acquired compliance.However could activities that pharmaceutical companies have a closer contact with the patients raise concerns that will unduly influence the prescribing process that may favor their own products.Also, new technologies and psychological techniques to improve compliance, but many patients take their drugs for social reasons that are affecting the ability of the company.